ReP USP - Resultado da busca

Artigo de periodico
Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A (2021)
Tozatto, Eduardo; Benzi, Jhohann Richard de Lima ; Rocha, Adriana; Coelho, Eduardo Barbosa ; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: FÁRMACOS, HIPERTENSÃO, FARMACOCINÉTICA, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOZATTO, Eduardo et al. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, v. 61, n. 3, p. 319-327, 2021Tradução . . Disponível em: https://doi.org/10.1002/jcph.1745. Acesso em: 04 ago. 2024.
APA
Tozatto, E., Benzi, J. R. de L., Rocha, A., Coelho, E. B., & Lanchote, V. L. (2021). Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, 61( 3), 319-327. doi:10.1002/jcph.1745
NLM
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1002/jcph.1745
Vancouver
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1002/jcph.1745
Artigo de periodico
Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients (2016)
Godoy, Ana Leonor Pardo Campos; Rocha, Adriana; Souza, Cacilda da Silva; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: METABOLISMO, FARMACOCINÉTICA, PSORÍASE, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Ana Leonor Pardo Campos et al. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients. The Journal of Clinical Pharmacology, v. 56, n. 5, p. 567-575, 2016Tradução . . Disponível em: https://doi.org/10.1002/jcph.630. Acesso em: 04 ago. 2024.
APA
Godoy, A. L. P. C., Rocha, A., Souza, C. da S., & Lanchote, V. L. (2016). Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients. The Journal of Clinical Pharmacology, 56( 5), 567-575. doi:10.1002/jcph.630
NLM
Godoy ALPC, Rocha A, Souza C da S, Lanchote VL. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 5): 567-575.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1002/jcph.630
Vancouver
Godoy ALPC, Rocha A, Souza C da S, Lanchote VL. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 5): 567-575.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1002/jcph.630
Trabalho de evento-resumo
Evidências acumuladas da associação linfocitoma cútis e fluoxetina (2010)
Maitto, Fernanda Britta; Ribeiro, Richard A.; Cardili, Renata Nahas; Chahud, Fernando; Souza, Cacilda da Silva
Source: Resumos. Conference titles: Congresso da Sociedade Brasileira de Dermatologia. Unidade: FMRP
Subjects: ANTIDEPRESSIVOS, LINFÓCITOS B
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAITTO, Fernanda Britta et al. Evidências acumuladas da associação linfocitoma cútis e fluoxetina. 2010, Anais.. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2010. . Acesso em: 04 ago. 2024.
APA
Maitto, F. B., Ribeiro, R. A., Cardili, R. N., Chahud, F., & Souza, C. da S. (2010). Evidências acumuladas da associação linfocitoma cútis e fluoxetina. In Resumos. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Maitto FB, Ribeiro RA, Cardili RN, Chahud F, Souza C da S. Evidências acumuladas da associação linfocitoma cútis e fluoxetina. Resumos. 2010 ;[citado 2024 ago. 04 ]
Vancouver
Maitto FB, Ribeiro RA, Cardili RN, Chahud F, Souza C da S. Evidências acumuladas da associação linfocitoma cútis e fluoxetina. Resumos. 2010 ;[citado 2024 ago. 04 ]
Artigo de periodico
Influence of quinidine, fluvoxamine, and ketoconazole on the enantioseletive pharmacokinetics of citalopram in rats (2008)
Rocha, Adriana; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: Canadian Journal of Physiology and Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOCINÉTICA, ANTIDEPRESSIVOS, ANSIOLÍTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Adriana e COELHO, Eduardo Barbosa e LANCHOTE, Vera Lúcia. Influence of quinidine, fluvoxamine, and ketoconazole on the enantioseletive pharmacokinetics of citalopram in rats. Canadian Journal of Physiology and Pharmacology, v. 86, n. 11, p. 770-776, 2008Tradução . . Disponível em: https://doi.org/10.1139/y08-088. Acesso em: 04 ago. 2024.
APA
Rocha, A., Coelho, E. B., & Lanchote, V. L. (2008). Influence of quinidine, fluvoxamine, and ketoconazole on the enantioseletive pharmacokinetics of citalopram in rats. Canadian Journal of Physiology and Pharmacology, 86( 11), 770-776. doi:10.1139/y08-088
NLM
Rocha A, Coelho EB, Lanchote VL. Influence of quinidine, fluvoxamine, and ketoconazole on the enantioseletive pharmacokinetics of citalopram in rats [Internet]. Canadian Journal of Physiology and Pharmacology. 2008 ; 86( 11): 770-776.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1139/y08-088
Vancouver
Rocha A, Coelho EB, Lanchote VL. Influence of quinidine, fluvoxamine, and ketoconazole on the enantioseletive pharmacokinetics of citalopram in rats [Internet]. Canadian Journal of Physiology and Pharmacology. 2008 ; 86( 11): 770-776.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1139/y08-088
Artigo de periodico
Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: application to pharmacokinetics (2007)
Rocha, Adriana; Marques, Maria P; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: Chirality. Unidades: FMRP, FCFRP
Subjects: ANTIDEPRESSIVOS, FARMACOCINÉTICA, METABOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Adriana et al. Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: application to pharmacokinetics. Chirality, v. 19, p. 793-801, 2007Tradução . . Disponível em: https://doi.org/10.1002/chir.20452. Acesso em: 04 ago. 2024.
APA
Rocha, A., Marques, M. P., Coelho, E. B., & Lanchote, V. L. (2007). Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: application to pharmacokinetics. Chirality, 19, 793-801. doi:10.1002/chir.20452
NLM
Rocha A, Marques MP, Coelho EB, Lanchote VL. Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: application to pharmacokinetics [Internet]. Chirality. 2007 ; 19 793-801.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1002/chir.20452
Vancouver
Rocha A, Marques MP, Coelho EB, Lanchote VL. Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: application to pharmacokinetics [Internet]. Chirality. 2007 ; 19 793-801.[citado 2024 ago. 04 ] Available from: https://doi.org/10.1002/chir.20452

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em